KYORIN Holdings, Inc. (4569.T)

JPY 1440.0

(-0.89%)

Inventory Summary of KYORIN Holdings, Inc.

  • KYORIN Holdings, Inc.'s latest annual inventory in 2023 was 53.47 Billion JPY , up 11.34% from previous year.
  • KYORIN Holdings, Inc.'s latest quarterly inventory in 2024 Q1 was 56.98 Billion JPY , up 6.57% from previous quarter.
  • KYORIN Holdings, Inc. reported annual inventory of 48.02 Billion JPY in 2022, up 13.76% from previous year.
  • KYORIN Holdings, Inc. reported annual inventory of 42.21 Billion JPY in 2021, up 9.46% from previous year.
  • KYORIN Holdings, Inc. reported quarterly inventory of 51.71 Billion JPY for 2023 Q2, up 7.62% from previous quarter.
  • KYORIN Holdings, Inc. reported quarterly inventory of 53.79 Billion JPY for 2023 Q3, up 4.01% from previous quarter.

Annual Inventory Chart of KYORIN Holdings, Inc. (2023 - 2004)

Historical Annual Inventory of KYORIN Holdings, Inc. (2023 - 2004)

Year Inventory Inventory Growth
2023 53.47 Billion JPY 11.34%
2022 48.02 Billion JPY 13.76%
2021 42.21 Billion JPY 9.46%
2020 38.56 Billion JPY 15.88%
2019 33.28 Billion JPY 30.93%
2018 25.41 Billion JPY 9.06%
2017 23.3 Billion JPY -4.39%
2016 24.37 Billion JPY -11.88%
2015 27.66 Billion JPY 6.7%
2014 25.92 Billion JPY 19.5%
2013 21.69 Billion JPY 8.83%
2012 19.93 Billion JPY -3.86%
2011 20.73 Billion JPY 1.84%
2010 20.36 Billion JPY -6.9%
2009 21.87 Billion JPY 20.26%
2008 18.18 Billion JPY -8.01%
2007 19.77 Billion JPY 35.28%
2006 14.61 Billion JPY 6.15%
2005 13.76 Billion JPY 35.61%
2004 10.15 Billion JPY 0.0%

Peer Inventory Comparison of KYORIN Holdings, Inc.

Name Inventory Inventory Difference
Pharma Foods International Co., Ltd. 6.71 Billion JPY -696.04%
Takeda Pharmaceutical Company Limited 1209.86 Billion JPY 95.581%
Sumitomo Pharma Co., Ltd. 115.35 Billion JPY 53.645%
Shionogi & Co., Ltd. 64.91 Billion JPY 17.632%
Wakamoto Pharmaceutical Co.,Ltd. 2 Billion JPY -2565.457%
Nippon Shinyaku Co., Ltd. 39.11 Billion JPY -36.713%
Kaken Pharmaceutical Co., Ltd. 17.16 Billion JPY -211.47%
Eisai Co., Ltd. 174.65 Billion JPY 69.385%
Morishita Jintan Co., Ltd. 3.18 Billion JPY -1578.807%
Hisamitsu Pharmaceutical Co., Inc. 21.17 Billion JPY -152.503%
Mochida Pharmaceutical Co., Ltd. 30.27 Billion JPY -76.597%
Fuso Pharmaceutical Industries,Ltd. 14.2 Billion JPY -276.496%
Nippon Chemiphar Co., Ltd. 10.72 Billion JPY -398.694%
Tsumura & Co. 117.61 Billion JPY 54.538%
Kissei Pharmaceutical Co., Ltd. 26.29 Billion JPY -103.339%
Torii Pharmaceutical Co., Ltd. 10.74 Billion JPY -397.766%
Towa Pharmaceutical Co., Ltd. 101.07 Billion JPY 47.097%
Fuji Pharma Co., Ltd. 19.37 Billion JPY -176.031%
Zeria Pharmaceutical Co., Ltd. 14.48 Billion JPY -269.019%
Taiko Pharmaceutical Co.,Ltd. 1.95 Billion JPY -2639.242%
Daito Pharmaceutical Co.,Ltd. 20.89 Billion JPY -155.96%
SymBio Pharmaceuticals Limited 232.03 Million JPY -22944.434%
MedRx Co., Ltd 10 Million JPY -534600.0%
Mizuho Medy Co.,Ltd. 1.59 Billion JPY -3248.975%
Solasia Pharma K.K. 122 Million JPY -43727.869%
Modalis Therapeutics Corporation 6.35 Million JPY -841549.614%
ASKA Pharmaceutical Holdings Co.,Ltd. 20.4 Billion JPY -162.082%
Sawai Group Holdings Co., Ltd. 100 Billion JPY 46.531%
Cyfuse Biomedical K.K. 46.04 Million JPY -116025.529%
Toho Holdings Co., Ltd. 87.28 Billion JPY 38.742%
Koa Shoji Holdings Co.,Ltd. 2.26 Billion JPY -2259.396%